Clinical trial
Observational Study on the Management, and Progression of Patients With Diabetic Macula Edema (DME)
NCT05966753 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study on the Management, and Progression of Patients With Diabetic Macula Edema (DME)
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 3, 2023
- Completion date
- December 31, 2023
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema